U‑BX Technology Ltd. (NASDAQ: UBXG) completed a registered direct offering of units priced at $0.30 each. Each unit consists of one Class A ordinary share and one warrant to purchase 0.3 of a share. The offering is expected to raise gross proceeds of approximately $4.55 million and is slated to close on or about April 29, 2026, subject to customary closing conditions. FT Global Capital, Inc. served as the exclusive placement agent and Kingswood Capital Partners, LLC as co‑placement agent, and the transaction is being made under an effective Form F‑3 registration statement (File No. 333‑291797) declared effective on December 15, 2025.
The financial backdrop for the capital raise is stark. For the six months ended December 31, 2025, U‑BX reported a net loss of $10.18 million on revenue of $11.65 million, a 33% decline from the same period in the prior year. Gross profit margins contracted from 1.2% to 0.3%, and the company posted negative earnings of $0.64 per share over the last twelve months. These figures illustrate a company that has been operating at a loss and whose profitability has been eroded by both declining sales and margin compression.
The offering is positioned as a general corporate and working‑capital measure, but the underlying need is driven by the company’s persistent losses and shrinking margins. The steep discount of $0.30 per unit—well below the previous closing price of roughly $1.15—signals the urgency of the financing and the market’s perception of the company’s financial fragility. The inclusion of warrants that allow purchase of 0.3 of a share further increases the potential for future dilution, a factor that has heightened investor concern.
Investor sentiment has turned sharply negative in response to the announcement. The steep discount, the potential for dilution, and the company’s deteriorating financial performance have all contributed to a strong sell‑off in the market. The reaction underscores the perception that the capital raise is a last‑ditch effort to shore up operations rather than a growth‑driven expansion.
Additional context: U‑BX has elected to rely on a Cayman Islands home‑country practice exemption from certain Nasdaq shareholder‑approval rules, providing greater flexibility for future financing. The placement agents and the effective Form F‑3 registration statement underscore the regulatory compliance and the structured nature of the offering.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.